Literature DB >> 7103680

Relapse in major depressive disorder: analysis with the life table.

M B Keller, R W Shapiro, P W Lavori, N Wolfe.   

Abstract

With the use of life tables to describe time while patients were well and subsequent rates of relapse for 75 patients after their recovery from an episodes of major depressive disorder in naturalistic study, a high risk of relapse was detected shortly after recovery. Twenty-four percent of patients relapsed within 12 weeks at risk, and 12% of patients relapsed with four weeks at risk. The presence of an underlying chronic depression and three or more previous affective episodes predicted a statistically significant increase in the rate of relapse. These data were used to develop an exponential model of relapse probability for a subgroup of the study population.

Entities:  

Mesh:

Year:  1982        PMID: 7103680     DOI: 10.1001/archpsyc.1982.04290080031005

Source DB:  PubMed          Journal:  Arch Gen Psychiatry        ISSN: 0003-990X


  30 in total

1.  Comparative efficacy and durability of continuation phase cognitive therapy for preventing recurrent depression: design of a double-blinded, fluoxetine- and pill placebo-controlled, randomized trial with 2-year follow-up.

Authors:  Robin B Jarrett; Michael E Thase
Journal:  Contemp Clin Trials       Date:  2010-05-06       Impact factor: 2.226

Review 2.  Continuation and maintenance therapy of early-onset major depressive disorder.

Authors:  Graham J Emslie; Taryn L Mayes; Maryse Ruberu
Journal:  Paediatr Drugs       Date:  2005       Impact factor: 3.022

3.  Assessing placebo response using Bayesian hierarchical survival models.

Authors:  D K Stangl; J B Greenhouse
Journal:  Lifetime Data Anal       Date:  1998       Impact factor: 1.588

4.  Computational Mechanisms of Effort and Reward Decisions in Patients With Depression and Their Association With Relapse After Antidepressant Discontinuation.

Authors:  Isabel M Berwian; Julia G Wenzel; Anne G E Collins; Erich Seifritz; Klaas E Stephan; Henrik Walter; Quentin J M Huys
Journal:  JAMA Psychiatry       Date:  2020-05-01       Impact factor: 21.596

5.  Cognitive reactivity, dysfunctional attitudes, and depressive relapse and recurrence in cognitive therapy responders.

Authors:  Robin B Jarrett; Abu Minhajuddin; Patricia D Borman; Lauren Dunlap; Zindel V Segal; Cindy L Kidner; Edward S Friedman; Michael E Thase
Journal:  Behav Res Ther       Date:  2012-02-21

6.  Cost utility of maintenance treatment of recurrent depression with sertraline versus episodic treatment with dothiepin.

Authors:  E J Hatziandreu; R E Brown; D A Revicki; R Turner; J Martindale; S Levine; J E Siegel
Journal:  Pharmacoeconomics       Date:  1994-03       Impact factor: 4.981

7.  Modelling the cost effectiveness of antidepressant treatment in primary care.

Authors:  D A Revicki; R E Brown; W Palmer; D Bakish; W W Rosser; S F Anton; D Feeny
Journal:  Pharmacoeconomics       Date:  1995-12       Impact factor: 4.981

Review 8.  Measuring quality of life in patients with depression or anxiety.

Authors:  D Whalley; S P McKenna
Journal:  Pharmacoeconomics       Date:  1995-10       Impact factor: 4.981

Review 9.  Prevalence and outcome of partial remission in depression.

Authors:  Richard Tranter; Claire O'Donovan; Praful Chandarana; Sidney Kennedy
Journal:  J Psychiatry Neurosci       Date:  2002-07       Impact factor: 6.186

10.  Evolving definitions of mental illness and wellness.

Authors:  Ronald W Manderscheid; Carol D Ryff; Elsie J Freeman; Lela R McKnight-Eily; Satvinder Dhingra; Tara W Strine
Journal:  Prev Chronic Dis       Date:  2009-12-15       Impact factor: 2.830

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.